Achieve Life Sciences ACHV
NASDAQ ACHV
$6.50 -0.01 (-0.15%)
At close: Oct 22, 2026 · 4:00 PM EDT

Achieve Life Sciences (ACHV) Amortization of Deferred Charges (2024 - 2026)

Updated

Analysis

Achieve Life Sciences (ACHV) Amortization of Deferred Charges (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Achieve Life Sciences 608.29 Mn 420.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11,000.00
Mar 31, 2026 12,000.00
Dec 31, 2025 11,000.00
Sep 30, 2025 13,000.00
Jun 30, 2025 14,000.00
Mar 31, 2025 14,000.00
Dec 31, 2024 14,000.00
API Access

Achieve Life Sciences Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=ACHV&period=max&api_key=YOUR_API_KEY